Literature DB >> 19090013

Timing of consent for the research use of surgically removed tissue: is postoperative consenting acceptable?

Robert Hewitt1, Peter H Watson, Rajiv Dhir, Roger Aamodt, Gerry Thomas, Dan Mercola, William E Grizzle, Manuel M Morente.   

Abstract

Mesh:

Year:  2009        PMID: 19090013     DOI: 10.1002/cncr.23999

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  6 in total

1.  Issues in collecting, processing and storing human tissues and associated information to support biomedical research.

Authors:  William E Grizzle; Walter C Bell; Katherine C Sexton
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

2.  Reflexive research ethics in fetal tissue xenotransplantation research.

Authors:  Bindu Panikkar; Natasha Smith; Phil Brown
Journal:  Account Res       Date:  2012       Impact factor: 2.622

3.  Cancer patient perceptions about biobanking and preferred timing of consent.

Authors:  Kathryn L Braun; Joann U Tsark; Amy Powers; Kristen Croom; Robert Kim; Francine C Gachupin; Paul Morris
Journal:  Biopreserv Biobank       Date:  2014-04       Impact factor: 2.300

4.  Oncology patients overwhelmingly support tissue banking.

Authors:  Jamie Bryant; Rob Sanson-Fisher; Elizabeth Fradgley; Timothy Regan; Breanne Hobden; Stephen P Ackland
Journal:  BMC Cancer       Date:  2015-05-17       Impact factor: 4.430

5.  Evolutionary concepts in biobanking - the BC BioLibrary.

Authors:  Peter H Watson; Janet E Wilson-McManus; Rebecca O Barnes; Sara C Giesz; Adrian Png; Richard G Hegele; Jacquelyn N Brinkman; Ian R Mackenzie; David G Huntsman; Anne Junker; Blake Gilks; Erik Skarsgard; Michael Burgess; Samuel Aparicio; Bruce M McManus
Journal:  J Transl Med       Date:  2009-11-12       Impact factor: 5.531

6.  A trial of consent procedures for future research with clinically derived biological samples.

Authors:  E Vermeulen; M K Schmidt; N K Aaronson; M Kuenen; M-J Baas-Vrancken Peeters; H van der Poel; S Horenblas; H Boot; V J Verwaal; A Cats; F E van Leeuwen
Journal:  Br J Cancer       Date:  2009-09-29       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.